EpiPen Price Fixing Scandal Ends in Huge Payout — Did Mylan Overcharge You? Check Details!

The EpiPen price-fixing scandal has resulted in over $1 billion in settlements from Mylan and Pfizer. If you purchased EpiPen or its generic versions between 2014 and 2025, you might be eligible for compensation. Learn how to file your claim before the May 29, 2025, deadline.

Published On:

EpiPen Price Fixing Scandal Ends in Huge Payout – The EpiPen price-fixing scandal has culminated in significant settlements involving Mylan (now part of Viatris), Pfizer, and Teva Pharmaceuticals. These settlements address allegations of anti-competitive practices that led to inflated prices for EpiPen devices.

EpiPen Price Fixing Scandal Ends in Huge Payout
EpiPen Price Fixing Scandal Ends in Huge Payout

If you purchased EpiPen or its generic versions directly from Mylan or Teva between March 13, 2014, and February 6, 2025, you might be eligible for compensation from the $73.5 million settlement. To file a claim, you need to provide proof of purchase, such as receipts or invoices. The deadline to submit a claim is May 29, 2025.

EpiPen Price Fixing Scandal Ends in Huge Payout

TopicDetails
Settlement Amounts– Mylan: $465M (2017), $264M (2022), $73.5M (2025)- Pfizer: $345M (2021), $50M (2023)
Eligibility PeriodMarch 13, 2014 – February 6, 2025
Claim DeadlineMay 29, 2025
Proof RequiredReceipts, invoices, or other purchase documentation
Official Claim Siteepipendppsettlement.com

The EpiPen price-fixing scandal has led to significant settlements aimed at compensating those affected by inflated prices. If you purchased EpiPen or its generic versions between March 13, 2014, and February 6, 2025, you may be eligible for compensation. Ensure you gather the necessary documentation and submit your claim by May 29, 2025, through the official website: epipendppsettlement.com.

The case also marks a turning point in public awareness and legislative interest in curbing drug pricing abuses and improving access to essential medications.

Understanding the EpiPen Price Surge

What Is an EpiPen?

An EpiPen is a life-saving device that delivers a dose of epinephrine to individuals experiencing severe allergic reactions (anaphylaxis). Quick administration can be the difference between life and death.

The Price Hike

In 2007, Mylan acquired the rights to market the EpiPen. Over the years, the company increased the price of a two-pack from around $100 to over $600 by 2016. This significant price hike led to public outcry and scrutiny from lawmakers.

Impact on Patients and Families

The price increases affected thousands of families, schools, and individuals who rely on the EpiPen for emergency situations. Many reported skipping doses, rationing usage, or seeking cheaper alternatives due to affordability issues, despite the life-saving importance of the device.

The Legal Battle: A Timeline

2017: $465 Million Settlement

Mylan agreed to pay $465 million to resolve claims that it misclassified EpiPen as a generic drug to avoid paying higher rebates to Medicaid, violating the False Claims Act.

2021: Pfizer’s $345 Million Settlement

Pfizer agreed to pay $345 million to resolve claims related to EpiPen price inflation.

2022: Mylan’s $264 Million Settlement

Mylan and Pfizer settled a class action lawsuit for $264 million over allegations of anti-competitive conduct, including delaying generic competition and engaging in “sham” patent litigation.

2023: Pfizer’s $50 Million Settlement

Pfizer agreed to pay $50 million to settle drug wholesalers’ EpiPen antitrust claims.

2025: Mylan’s $73.5 Million Settlement

Mylan settled with drug wholesalers for $73.5 million over allegations of conspiring to delay the launch of a generic EpiPen, resulting in overcharges.

Regulatory Reforms After the Scandal

Following the controversy, U.S. lawmakers and regulatory agencies pushed for more transparency in drug pricing. Discussions began around generic alternatives, improving FDA approval timelines, and preventing companies from exploiting patent loopholes to maintain monopolies.

Several bills were introduced in Congress targeting drug pricing reform, including the introduction of the CREATES Act to curb anti-competitive behaviors in the pharmaceutical industry.

How to File a Claim For EpiPen Price Fixing Scandal?

Step 1: Determine Eligibility

You may be eligible if you purchased EpiPen or its generic versions directly from Mylan or Teva between March 13, 2014, and February 6, 2025.

Step 2: Gather Documentation

Collect receipts, invoices, or other proof of purchase.

Step 3: Submit Your Claim

Visit the official settlement website: epipendppsettlement.com and follow the instructions to file your claim.

Step 4: Await Confirmation

After submission, you will receive confirmation and further instructions if additional information is needed.

Botanic Tonics Faces Lawsuit Over Feel Free Wellness Drink — Check Settlement Amount!

MGM Resorts Data Breach Settlement: How to Claim Your Share of the $45 Million Fund

LoanCare Data Leak Settlement Could Mean a Check for You — Check Details Today!

FAQs About EpiPen Price Fixing Scandal

Q1: What if I no longer have my receipts?

A1: While proof of purchase is required, contact the settlement administrator for guidance on alternative documentation.

Q2: Can I file a claim if I purchased EpiPen for personal use?

A2: Yes, individuals who purchased EpiPen for personal use are eligible to file a claim.

Q3: How will the settlement funds be distributed?

A3: Funds will be distributed proportionally based on the number of valid claims and the amount of EpiPen purchased.

Q4: Is there a deadline to file a claim?

A4: Yes, the deadline to submit a claim is May 29, 2025.

Q5: Will these settlements affect future EpiPen pricing?

A5: While the settlements themselves don’t regulate future prices, public pressure and increased generic competition may help stabilize or reduce EpiPen costs moving forward.

Author
Anjali Tamta
Hi, I'm a finance writer and editor passionate about making money matters simple and relatable. I cover markets, personal finance, and economic trends — all with the goal of helping you make smarter financial decisions.

Follow Us On

Leave a Comment